PCSK9 and cardiovascular disorder: The discovery of the marked effect of PCSK9 on LDL-C serum level has led to the rapid development of PCSK9 inhibitors for the treatment of hypercholesterolemia to reduce the risk of subsequent cardiovascular disease (CVD) development (Dullaart, 2017).